Get in touch today 206.598.4100 or

Schedule an Appointment

Kent Wallner, M.D.

Associate Professor

Locations of Practice

Overview

Dr. Wallner is an expert in brachytherapy – a treatment that involves placing small radioactive seeds throughout the prostate.  He has been performing brachytherapy procedures for 25 years and performs about 400 a year.

Patient Care Philosophy

Patient care is one of the greatest honors. I treasure the time I can spend with my patients and their families.

Education and Training

College: Miami University, Oxford, OH 1978

Medical Education: Ohio State University, Columbus, OH 1981

Internship: Cook County Hospital, Chicago, IL 1983

Residency: University of California, San Francisco, CA 1987

Chief Resident: University of California, San Francisco, CA 1987

Selected Publications from a Total of 214

Wallner K, Sutlief S, Bergasagel C, Merrick G. Severe rectal complications after prostate brachytherapy. Radiotherapy and Oncology 114:272, 2015.

Taira A, Merrick GS, Butler WM, Galbreath RW, Fiano R, Wallner KE, Adamovich E. Time to failure after definitive therapy for prostate cancer: Implications for the importance of aggressive local treatment. J Contemp Brachy 5:215-221, 2013.

Taira A, Merrick GS, Galbreath RW, Butler WM, Lief JH, Adamovich E, Wallner KE. Long-term outcomes od prostate cancer patients with Gleason pattern 5 treated with combined brachytherapy and external beam radiotherapy. Brachytherapy 12:408-414, 2013.

Taira A, Merrick GS, Galbreath RW, Butler WM, Bennet A, Adamovich E Lief JH, Wallner KE. Prognostic importance of tobacco use in men receiving definitive prostate brachytherapy. Brachytherapy 11:446-451, 2012.

Taira A, Merrick GS, Galbreath RW, Butler WM, Adamovich E, Wallner KE. Prognostic importance of small prostate size in men receiving definitive prostate brachytherapy. IJROBP 84:396-401, 2012.

Taira AV, Merrick GS, Galbreth RW, Butler WM, Lief JH, Adamovich E, Wallner KE. Distant metastases following permanent interstitial brachytherapy for patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 82, e225-e32, 2012

Taira AV, Merrick GS, Galbreth RW, Butler WM, Lief JH, Allen ZA, Wallner KE. Serum testoterone kinetics after brachytherapy for clnincally localized prostate cancer. Int J Radiat Oncol Biol Phys 82, e33-e38, 2012

Bittner N, Merrick GS, Galbreth RW, Butler WM, Lief JH, Allen ZA, Wallner KE. Erectile dysfunction in patients with prostate cancer treated with permanent interstitial brachytherapy. BJUI 109:220-225, 2011.

Fang LC, Merrick GS, Butler WM, Labreath RW, Murray BC, Reed JL, Admovich E, Wallner KE: High-risk prostate cancer with Gleason score 8-10 and PSA level <15 mg/ml treated with permanent interstitial brachytherapy. Int J Radiat Oncol Biol Phys 81, 992-996, 2011

King B, Butler WM, Merrick GS, Kurko BS, Reed JL, Murray BC, Wallner KE: Electromagnetic transponders indicate prostate size increase followed by decrease during the course of external beam radiation therapy.. Int J Radiat Oncol Biol Phys 79, 1350-1357, 2011

Research Interests

  • Head and neck cancer accelerated treatment protocol
  • Esophageal cancer accelerated treatment protocol